400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / c-Met/HGFR / BMS 777607
CAS No.: 1025720-94-8
Synonyms: BMS 817378;ASLAN-002
BMS-777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50 of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, being 40-fold selective for Met-related targets versus Lck, VEGFR-2, and TrkA/B, and more than 500-fold greater selectivity versus all other receptor and non receptor kinases.
生物活性
靶点 | Axl IC50:1.1nM | c-Met IC50:3.9nM | Ron IC50:1.8nM | Tyro3 IC50:4.3nM |
动物研究 | |||||||||||||||||||||||||||||||||||||||||
剂量 | Mice: 10 mg/kg - 25 mg/kg[1] (p.o.); nude Mice: 50 mg/kg[2] (p.o.) | ||||||||||||||||||||||||||||||||||||||||
给药途径 | p.o. | ||||||||||||||||||||||||||||||||||||||||
动物药代数据 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01721148 | Malignant Solid Tumour | Phase 1 | Completed | - | - |
NCT00605618 | Advanced Solid Tumors | Phase 1 Phase 2 | Completed | - | Australia, New South Wales ... more >> Local Institution Camperdown, New South Wales, Australia, 2050 Local Institution Kogarah, New South Wales, Australia, 2217 Collapse << |
实验方案
技术信息
CAS号 | 1025720-94-8 | 储存条件 |
|
|||||||||
分子式 | C25H19ClF2N4O4 | 运输 | 蓝冰 | |||||||||
分子量 | 512.89 | 别名 | BMS 817378;ASLAN-002 | |||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
CHRF | 10 μM | Function assay | - | inhibits cell division | 25304900 |
DU145 | 0.1 μM | Function assay | - | exhibits inhibitory effect on HGF-induced cell scattering | 20515943 |
DU145 | 0.01 μM | Function assay | - | suppresses HGF-induced cell migration | 20515943 |
DU145 | 0.1 μM | Function assay | - | impairs HGF-mediated cell invasion | 20515943 |
GTL-16 | - | Kinase assay | - | inhibits Met kinase with IC50 of 100 nM | 19260711 |
H1993 | ~10 μM | Growth inhibitory assay | - | IC50=150 nM | 19260711 |
HPDE | 10 μM | Function assay | - | blocks constitutive activation and decreased AKT signaling | 26477314 |
KHT | - | Kinase assay | - | blocks the c-Met signaling pathway with IC50 of 10 nM | 22286523 |
KHT | ~1 μM | Function assay | - | prevents spontaneous KHT cell scattering with IC50 of 0.1-0.5 μM | 22286523 |
KHT | ~0.5 μM | Function assay | - | inhibits cell migration | 22286523 |
KHT | ~0.5 μM | Function assay | - | inhibits cell invasion | 22286523 |
KHT | ~10 μM | Growth inhibitory assay | - | inhibits KHT cell proliferation | 22286523 |
PC-3 | 0.1 μM | Function assay | - | exhibits inhibitory effect on HGF-induced cell scattering | 20515943 |
PC-3 | 0.01 μM | Function assay | - | suppresses HGF-induced cell migration | 20515943 |
PC-3 | 0.1 μM | Function assay | - | impairs HGF-mediated cell invasion | 20515943 |
PC-3 | ~10 μM | Growth inhibitory assay | - | reduces cell proliferation | 20515943 |
SF126 | ~3 μM | Kinase assay | - | blocks AXL phosphorylation | 26848524 |
SF126 | 12.5 μM | Cytoxicity assay | - | decreases glioma cell viability | 26848524 |
SF126 | 12.5 μM | Apoptosis assay | - | induces glioma cell apoptosis | 26848524 |
SF126 | 12.5 μM | Function assay | - | blocks glioma cell migration and invasive growth pattern | 26848524 |
T-47D | ~5 μM | Growth inhibitory assay | - | inhibits cell proliferation | 23468529 |
T-47D | 10 μM | Function assay | - | Induces polyploidy by 86 % | 23468529 |
T-47D | 10 μM | Function assay | - | inhibits AURK-B function and induces its protein degradation | 23468529 |
U118MG | ~3 μM | Kinase assay | - | blocks AXL phosphorylation | 26848524 |
U118MG | 12.5 μM | Cytoxicity assay | - | decreases glioma cell viability | 26848524 |
U118MG | 12.5 μM | Apoptosis assay | - | induces glioma cell apoptosis | 26848524 |
U118MG | 12.5 μM | Function assay | - | blocks glioma cell migration and invasive growth pattern | 26848524 |
U87 | ~10 μM | Growth inhibitory assay | - | IC50=160 nM | 19260711 |
ZR-75-1 | ~5 μM | Growth inhibitory assay | - | inhibits cell proliferation | 23468529 |
ZR-75-1 | 10 μM | Function assay | - | Induces polyploidy by 88% | 23468529 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01721148 | Malignant Solid Tumour | Phase 1 | Completed | - | - |
NCT00605618 | Advanced Solid Tumors | Phase 1 Phase 2 | Completed | - | Australia, New South Wales ... more >> Local Institution Camperdown, New South Wales, Australia, 2050 Local Institution Kogarah, New South Wales, Australia, 2217 Collapse << |
靶点 | Description | IC50 |
---|---|---|
Axl | IC50:1.1nM | |
c-Met | IC50:3.9nM | |
Ron | IC50:1.8nM | |
Tyro3 | IC50:4.3nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网